rkaovla | Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/4rkaovla_hasAnnotation_C0003015> <https://research.tib.eu/covid-19/entity/4rkaovla_hasAnnotation_C0521942>
?:creator	<https://research.tib.eu/covid-19/entity/Bottino%2C_Leonardo_Grabinski%3B_Fuchs%2C_Fl%C3%A1vio_Danni>
?:doi	10.1080/14779072.2021.1862548
?:doi	<https://research.tib.eu/covid-19/entity/10.1080/14779072.2021.1862548>
?:journal	Expert_review_of_cardiovascular_therapy
?:license	unk
?:pmid	<https://research.tib.eu/covid-19/entity/33297777>
?:pmid	33297777
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/COVID-19>
is ?:relation_isRelatedTo_publication of	<https://research.tib.eu/covid-19/entity/4rkaovla_HAS_C0003015_TREATS_C0020538> <https://research.tib.eu/covid-19/entity/4rkaovla_HAS_C0521942_TREATS_C0020538>
?:source	Medline
?:title	Response to the letter to the editor entitled \'Angiotensin-II receptor blockers or angiotensin converting enzyme inhibitors for the treatment of hypertension amid COVID-19 pandemic\'.
?:type	<https://research.tib.eu/covid-19/vocab/Publication>
?:year	2020-12-10

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/4rkaovla>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/4rkaovla>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all